Literature DB >> 11347669

Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients.

A C Fluit1, F J Schmitz, J Verhoef.   

Abstract

The frequency of isolation of pathogens that cause different types of infections is an important guide for empiric therapy. As part of the SENTRY Antimicrobial Surveillance Program, the frequency of isolation of different bacterial species from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients was determined. A total of 15,704 isolates were collected in 1997 and 1998 from 24 university hospitals in 14 European countries: 9,194 from bloodstream, 2,052 from nosocomial pneumonia, 2,320 from skin and soft tissue, and 2,138 from urinary tract infections. More than 95% of all bacterial infections were caused by only 15 different genera. Staphylococcus spp. and Escherichia spp, accounted for more than 50% of the infectious isolates, with the exception of those obtained from cases of nosocomial pneumonia. In the latter type of infection, isolates belonging to these two genera were responsible for 30% of the infections. An analysis at the individual species level showed that Escherichia coli caused a large proportion of bloodstream and urinary tract infections (20.8% and 49.3% of isolates, respectively). Staphylococcus aureus was the main causative species for nosocomial pneumonia and skin and soft tissue infections (21.5% and 37.4% of isolates, respectively). In addition, Pseudomonas aeruginosa played an important role in all types of infection analyzed.

Entities:  

Mesh:

Year:  2001        PMID: 11347669     DOI: 10.1007/s100960100455

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

2.  Defining, treating and preventing hospital acquired pneumonia: European perspective.

Authors:  Antoni Torres; Santiago Ewig; Harmut Lode; Jean Carlet
Journal:  Intensive Care Med       Date:  2008-11-07       Impact factor: 17.440

3.  Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.

Authors:  Hsien Chang Chang; Yu Fang Wei; Lenie Dijkshoorn; Mario Vaneechoutte; Chung Tao Tang; Tsung Chain Chang
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia.

Authors:  Sotiria Palioura; Allister Gibbons; Darlene Miller; Terrence P OʼBrien; Eduardo C Alfonso; Oriel Spierer
Journal:  Cornea       Date:  2018-03       Impact factor: 2.651

5.  A novel eukaryote-made thermostable DNA polymerase which is free from bacterial DNA contamination.

Authors:  Hideki Niimi; Masashi Mori; Homare Tabata; Hiroshi Minami; Tomohiro Ueno; Shirou Hayashi; Isao Kitajima
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

6.  Colonization, competition, and dispersal of pathogens in fluid flow networks.

Authors:  Albert Siryaporn; Minyoung Kevin Kim; Yi Shen; Howard A Stone; Zemer Gitai
Journal:  Curr Biol       Date:  2015-04-02       Impact factor: 10.834

Review 7.  Bacterial resistance: a sensitive issue complexity of the challenge and containment strategy in Europe.

Authors:  W T M Jansen; J T van der Bruggen; J Verhoef; A C Fluit
Journal:  Drug Resist Updat       Date:  2006-06-27       Impact factor: 18.500

8.  Safety and efficacy of tigecycline in treatment of skin and skin structure infections: results of a double-blind phase 3 comparison study with vancomycin-aztreonam.

Authors:  Johannes Breedt; Jüri Teras; Janis Gardovskis; Frans Jacobus Maritz; Tiit Vaasna; Douglas Patrick Ross; Martine Gioud-Paquet; Nathalie Dartois; Evelyn J Ellis-Grosse; Evan Loh
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

9.  Blechnum orientale Linn - a fern with potential as antioxidant, anticancer and antibacterial agent.

Authors:  How Y Lai; Yau Y Lim; Kah H Kim
Journal:  BMC Complement Altern Med       Date:  2010-04-30       Impact factor: 3.659

10.  Empirical antibiotics use in soft tissue infections.

Authors:  Rodger Shortt; Achilleas Thoma
Journal:  Can J Plast Surg       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.